Immuneering Corp. (IMRX)
5.53
-0.03
(-0.54%)
USD |
NASDAQ |
Apr 20, 16:00
5.52
-0.01
(-0.18%)
Pre-Market: 08:31
Immuneering EPS Diluted (Quarterly) : -0.1793 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| X4 Pharmaceuticals, Inc. | -0.2164 |
| Theravance Biopharma, Inc. | 1.150 |
| vTv Therapeutics, Inc. | -0.5752 |
| Design Therapeutics, Inc. | -0.2724 |
| Tango Therapeutics, Inc. | -0.2945 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.58M |
| Total Expenses (Quarterly) | 11.58M |
| Enterprise Value | 188.52M |
| Earnings Yield | -24.97% |
| Normalized Earnings Yield | -24.97 |